Form D · Other Health Care
Motus GI Medical Technologies, Ltd.
Tirat Carmel, L3 · CIK 0001691987
Offering snapshot reported Feb 7, 2017 · SEC filing
- Reported sold
- $13.8M Offering amount: $13.8M
- Investors reported
- 56 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 26, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 7, 2017 | Initial | $13,766,017 | No comparison | 56 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $553K
- Finders' fees
- $0
- Form D file number
- 021-280162
Convertible Promissory Notes
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Aegis Capital Corporation | 15007 |
Source: Form D, filed Feb 7, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Hochman | Director |
| Gary Jacobs | Director |
| James Martin | Executive |
| Mark Pomeranz | Director, Executive |
| Darren Sherman | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
Keren Hayesod 22
Tirat Carmel, L3, 3902638
Tirat Carmel, L3, 3902638